/Companies

DiA Imaging Analysis

Acquired

13 known investors

Find your way into DiA Imaging Analysis

Sign up to find every way you can get introduced to DiA Imaging Analysis

  • Your email: who you already know at DiA Imaging Analysis, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the DiA Imaging Analysis team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.

Also known as DiA · DiA Imaging Analysis Ltd.

Investors · 13

Also in the syndicate · 6

Alchimia VenturesDefta HealthcareDr. Shmuel CabillyICON Community FundMindset VenturesXTX Ventures

Key figures

latest reported
Countries where software is deployedAug 2021more than 20
EmployeesJan 202519 people
End-users with access to softwareAug 20213,000 users
FDA/CE-cleared solutionsAug 20217 clearances
Total funding raised to dateAug 2021$25M
U.S. FDA clearancesFeb 20239 clearances

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 5

launches, deals, and filings
May 2023
Philips to acquire DiA Imaging Analysis for nearly $100M

Philips agreed to acquire DiA for slightly less than $100 million, with most of the consideration paid upfront and the remainder tied to business milestones. The deal was disclosed to the Tel Aviv Stock Exchange on May 7, 2023 by largest shareholder Capital Point, which held a 15% stake and stood to receive about $7 million; DiA confirmed it on May 10, 2023, and CEO Hila Goldman-Aslan was to remain with the team.

$100M source ↗

Feb 2023
Ninth U.S. FDA clearance

Received its ninth U.S. FDA clearance, for a solution that assists with cardiac ultrasound image acquisition.

source ↗

Aug 2021
$14M Series B round closed

Closed a $14 million Series B led by a consortium of new and existing international investors, bringing total funding to $25 million, to expand its FDA-cleared and CE-marked product portfolio, pursue partnerships with ultrasound vendors, PACS and healthcare IT companies, resellers and distributors, and grow presence in Asia, Europe and the U.S.

$14M source ↗

Jan 2020
Philips acquires minority interest in DiA

Philips, which had previously partnered with DiA, acquired a minority interest in the company in 2020.

source ↗

Aug 2018
DiA raises $5M led by Connecticut Innovations

Closed a $5 million funding round led by Connecticut Innovations with participation from Defta Healthcare, existing investors and a government grant from the Israel Innovation Authority, to be used for market penetration with FDA/CE-approved tools and support teams in the U.S., Europe and Asia.

$5M source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 11

primary sources listed

11 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does DiA Imaging Analysis do?
AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.
Who are DiA Imaging Analysis's investors?
DiA Imaging Analysis's investors include Agate Medical Investments LP, Mindset Venture, Connecticut Innovations, DEFTA Partners, Israel Innovation Authority, Philips Ventures, XTX Markets.